Report Detail

Request for Sample of this report

Pharma & Healthcare Global Migraine Headache Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514020
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.
According to our (Global Info Research) latest study, the global Migraine Headache Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Migraine Headache Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Migraine Headache Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Migraine Headache Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Migraine Headache Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Migraine Headache Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Migraine Headache Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Migraine Headache Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Johnson & Johnson, GSK and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Migraine Headache Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Market segment by Application
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
Market segment by players, this report covers
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Migraine Headache Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Migraine Headache Drugs, with revenue, gross margin and global market share of Migraine Headache Drugs from 2018 to 2023.
Chapter 3, the Migraine Headache Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Migraine Headache Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Migraine Headache Drugs.
Chapter 13, to describe Migraine Headache Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Migraine Headache Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Migraine Headache Drugs by Type
    • 1.3.1 Overview: Global Migraine Headache Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Migraine Headache Drugs Consumption Value Market Share by Type in 2022
    • 1.3.3 Almotriptan
    • 1.3.4 Eletriptan
    • 1.3.5 Sumatriptan
    • 1.3.6 Rizatriptan
    • 1.3.7 Zolmitriptan
    • 1.3.8 Naratriptan
    • 1.3.9 Frovatriptan
    • 1.3.10 Others
  • 1.4 Global Migraine Headache Drugs Market by Application
    • 1.4.1 Overview: Global Migraine Headache Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Acute Migraine
    • 1.4.3 Common Migraine
    • 1.4.4 Classic Migraine
    • 1.4.5 Chronic Migraine
    • 1.4.6 Other Migraines
  • 1.5 Global Migraine Headache Drugs Market Size & Forecast
  • 1.6 Global Migraine Headache Drugs Market Size and Forecast by Region
    • 1.6.1 Global Migraine Headache Drugs Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Migraine Headache Drugs Market Size by Region, (2018-2029)
    • 1.6.3 North America Migraine Headache Drugs Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Migraine Headache Drugs Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Migraine Headache Drugs Market Size and Prospect (2018-2029)
    • 1.6.6 South America Migraine Headache Drugs Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Migraine Headache Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Migraine Headache Drugs Product and Solutions
    • 2.1.4 Pfizer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Migraine Headache Drugs Product and Solutions
    • 2.2.4 Novartis Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Johnson & Johnson
    • 2.3.1 Johnson & Johnson Details
    • 2.3.2 Johnson & Johnson Major Business
    • 2.3.3 Johnson & Johnson Migraine Headache Drugs Product and Solutions
    • 2.3.4 Johnson & Johnson Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK Migraine Headache Drugs Product and Solutions
    • 2.4.4 GSK Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 GSK Recent Developments and Future Plans
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Migraine Headache Drugs Product and Solutions
    • 2.5.4 Merck Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Merck Recent Developments and Future Plans
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Migraine Headache Drugs Product and Solutions
    • 2.6.4 Eli Lilly Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Eli Lilly Recent Developments and Future Plans
  • 2.7 Teva
    • 2.7.1 Teva Details
    • 2.7.2 Teva Major Business
    • 2.7.3 Teva Migraine Headache Drugs Product and Solutions
    • 2.7.4 Teva Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Teva Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Migraine Headache Drugs Product and Solutions
    • 2.8.4 AstraZeneca Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Sun Pharma
    • 2.9.1 Sun Pharma Details
    • 2.9.2 Sun Pharma Major Business
    • 2.9.3 Sun Pharma Migraine Headache Drugs Product and Solutions
    • 2.9.4 Sun Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sun Pharma Recent Developments and Future Plans
  • 2.10 Grunenthal
    • 2.10.1 Grunenthal Details
    • 2.10.2 Grunenthal Major Business
    • 2.10.3 Grunenthal Migraine Headache Drugs Product and Solutions
    • 2.10.4 Grunenthal Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Grunenthal Recent Developments and Future Plans
  • 2.11 Endo Pharmaceuticals
    • 2.11.1 Endo Pharmaceuticals Details
    • 2.11.2 Endo Pharmaceuticals Major Business
    • 2.11.3 Endo Pharmaceuticals Migraine Headache Drugs Product and Solutions
    • 2.11.4 Endo Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
  • 2.12 Mylan
    • 2.12.1 Mylan Details
    • 2.12.2 Mylan Major Business
    • 2.12.3 Mylan Migraine Headache Drugs Product and Solutions
    • 2.12.4 Mylan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Mylan Recent Developments and Future Plans
  • 2.13 Bayer
    • 2.13.1 Bayer Details
    • 2.13.2 Bayer Major Business
    • 2.13.3 Bayer Migraine Headache Drugs Product and Solutions
    • 2.13.4 Bayer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Bayer Recent Developments and Future Plans
  • 2.14 Amneal Pharmaceuticals
    • 2.14.1 Amneal Pharmaceuticals Details
    • 2.14.2 Amneal Pharmaceuticals Major Business
    • 2.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Product and Solutions
    • 2.14.4 Amneal Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Amneal Pharmaceuticals Recent Developments and Future Plans
  • 2.15 Apotex
    • 2.15.1 Apotex Details
    • 2.15.2 Apotex Major Business
    • 2.15.3 Apotex Migraine Headache Drugs Product and Solutions
    • 2.15.4 Apotex Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Apotex Recent Developments and Future Plans
  • 2.16 Ajanta Pharma
    • 2.16.1 Ajanta Pharma Details
    • 2.16.2 Ajanta Pharma Major Business
    • 2.16.3 Ajanta Pharma Migraine Headache Drugs Product and Solutions
    • 2.16.4 Ajanta Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Ajanta Pharma Recent Developments and Future Plans
  • 2.17 Allergan
    • 2.17.1 Allergan Details
    • 2.17.2 Allergan Major Business
    • 2.17.3 Allergan Migraine Headache Drugs Product and Solutions
    • 2.17.4 Allergan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Migraine Headache Drugs Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Migraine Headache Drugs by Company Revenue
    • 3.2.2 Top 3 Migraine Headache Drugs Players Market Share in 2022
    • 3.2.3 Top 6 Migraine Headache Drugs Players Market Share in 2022
  • 3.3 Migraine Headache Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Migraine Headache Drugs Market: Region Footprint
    • 3.3.2 Migraine Headache Drugs Market: Company Product Type Footprint
    • 3.3.3 Migraine Headache Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Migraine Headache Drugs Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Migraine Headache Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Migraine Headache Drugs Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Migraine Headache Drugs Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Migraine Headache Drugs Consumption Value by Type (2018-2029)
  • 6.2 North America Migraine Headache Drugs Consumption Value by Application (2018-2029)
  • 6.3 North America Migraine Headache Drugs Market Size by Country
    • 6.3.1 North America Migraine Headache Drugs Consumption Value by Country (2018-2029)
    • 6.3.2 United States Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Migraine Headache Drugs Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Migraine Headache Drugs Consumption Value by Type (2018-2029)
  • 7.2 Europe Migraine Headache Drugs Consumption Value by Application (2018-2029)
  • 7.3 Europe Migraine Headache Drugs Market Size by Country
    • 7.3.1 Europe Migraine Headache Drugs Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 7.3.3 France Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Migraine Headache Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Migraine Headache Drugs Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Migraine Headache Drugs Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Migraine Headache Drugs Consumption Value by Region (2018-2029)
    • 8.3.2 China Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 8.3.5 India Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Migraine Headache Drugs Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Migraine Headache Drugs Consumption Value by Type (2018-2029)
  • 9.2 South America Migraine Headache Drugs Consumption Value by Application (2018-2029)
  • 9.3 South America Migraine Headache Drugs Market Size by Country
    • 9.3.1 South America Migraine Headache Drugs Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Migraine Headache Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Migraine Headache Drugs Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Migraine Headache Drugs Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Migraine Headache Drugs Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Migraine Headache Drugs Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Migraine Headache Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Migraine Headache Drugs Market Drivers
  • 11.2 Migraine Headache Drugs Market Restraints
  • 11.3 Migraine Headache Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Migraine Headache Drugs Industry Chain
  • 12.2 Migraine Headache Drugs Upstream Analysis
  • 12.3 Migraine Headache Drugs Midstream Analysis
  • 12.4 Migraine Headache Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Migraine Headache Drugs. Industry analysis & Market Report on Migraine Headache Drugs is a syndicated market report, published as Global Migraine Headache Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Migraine Headache Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,641.32
    		3,961.98
    		5,282.64
    		3,128.52
    		4,692.78
    		6,257.04
    		492,802.80
    		739,204.20
    		985,605.60
    		291,728.40
    		437,592.60
    		583,456.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo